Under the umbrella of Dissemination and Communication strategy
We are pleased to invite you to join us for the first open PharmaLedger webinar. At this free webinar, we will bring together our members to present and discuss the current state of the Blockchain-enabled Supply Chain use cases.
This is part of a series of webinars aimed at fostering greater alignment and a common understanding of PharmaLedger’s activities, approaches and progress among its members and the general public.
Lynn Wang (Johnson & Johnson) co-leads PharmaLedger’s Supply Chain use case domain and she will deliver the introduction to PharmaLedger as well as the context of the selected Supply Chain use cases for this webinar.
- 2nd Dec at 2:00pm CET
Reimagining the Clinical Supply Chain with Blockchain
In this presentation, we focus on improving supply chain track and trace capabilities, one block at a time.
Finished Goods Traceability – The PharmaLedger Vision
Patient centricity and patient safety combined with increasingly personalized treatments put a series of additional requirements on pharmaceutical supply chains. The presentation will explore the finished goods value chain journey from the perspectives of different stakeholders, as finished goods traceability is central to meeting the requirements of many other use cases.
Dr. Jan WortmannBayer
ePI – Electronic Product Information or eLeaflet
This presentation will discuss PharmaLedger’s efforts to digitize medicine package inserts with a common industry approach. It’ll also present how the project is using blockchain to create a trusted digital solution for the process of these package inserts – creation, update and final approval by regulatory authorities. The aim is to deliver the most updated medicine leaflet to patients, lower environmental impact and make a step towards patient empowerment in the digital healthcare ecosystem.
This use case focuses on empowering patients by creating new anti-counterfeiting capabilities through public-private collaboration and the use of blockchain technology.
Dr. Alberto LópezINCM